No four consecutive quarters could be summed for EPS (Diluted); these figures use the latest fiscal year, not a trailing twelve months.
Some figures named '(TTM)' on this payload are the latest FISCAL YEAR, not a trailing twelve months — eps_ttm (fiscal year ended 2025-12-31). No four consecutive quarters could be summed for them — for an IFRS 20-F filer that is every income-statement line (no quarterly income statement is tagged to EDGAR at all); for a US filer it is usually one line the quarterly tagging skips. Each field's own basis is on field_basis.
full derived coverage requires a plan
Output of a disclosed model — assumptions may be wrong. Research, not investment advice. See the Disclaimer.
— Months · distinct values (the real sample size).
Metric
Today
Own median
Own range
%ile
z
Sector med.
mo · distinct
10.09×
25.86×
no band (19 mo · 18 distinct)
—
—
24.86×
19 · 18
ROE (FY)
38.9%
only 7 monthly observations — under the 12-month floor for a series line.
ROIC (FY)
20.4%
only 7 monthly observations — under the 12-month floor for a series line.
18.7%
—
no band (19 mo · 2 distinct)
—
—
−21.3%
19 · 2
6.5%
7.8%
no band (19 mo · 19 distinct)
—
—
5.1%
19 · 19
EPS Growth 3Y (FY)
4.5%
only 2 monthly observations — under the 12-month floor for a series line. P/E and EPS growth are reconstructed for US-domestic 10-K filers only — a 20-F/40-F foreign private issuer's ADR trades in USD while its EPS is reported in the native currency, so no multiple is reconstructed rather than a wrong one.
Sales Growth 3Y (FY)
0.8%
only 2 monthly observations — under the 12-month floor for a series line.
Market Cap
$15.25B
not reconstructed — market cap was removed from the historical pass (never a ranking factor, and a reconstructed share count carries look-ahead risk). The single stored value is the forward-captured snapshot, not a series.
P/E (point-in-time)Health Care median, same monthshaded = own p25–p75 · dashed = own median · right-edge tick = today
shown for reference only — the reconstructed distribution did not clear the band gate, so no rank is quoted.
Multiple-implied price ladder · Full
Filed earnings only.
no P/E ladder — 19 monthly observations — a series is shown but no percentile band is quoted (the disclosed gate is 60 months).
Ladder not drawn for this name — the reason is above.ⓘ
Not a forecast: each row re-prices today's filed earnings at a multiple this company itself once traded at. It abstains rather than guess on a loss year or a broken per-share basis.
Every month uses only what was filed by then, split-adjusted. Delisted names are absent and a trough year can throw one huge reading, so read the median, not the edges.
Percentile through time (point-in-time cohort)
Loading the monthly cohort placement…
▸Comp setname your own peers — pick a pool or add tickers
Growth, restated as sharewhere each pace has to END UP, by 2030
Its own realised pace2.6% → 1.8%
The pace the price requires— The growth today's price requires (our reverse-DCF) is a Pro metric — the realized-pace runway above is free.
SOLV share over time4 published years
Calendar year
2022
2023
2024
2025
Share of covered pool
3.5%
3.0%
2.8%
2.6%
share_5y: this company has no 2020… · coverage: 152 of the 160 members that…
Share of covered industry revenue · n=154 in Health Care Equipment & Supplies · CY2025 pool · built 2026-08-22 not market shareⓘ
Covered filers only, not market share — private and uncovered companies are missing, so every share here reads high. Years are FX-converted and published only once most of the pool has filed.
